Related Experiment Video
Updated: Aug 15, 2026

Senescence Detection Using Reflected Light in Adipose Stromal Vascular Fraction
Published on: June 5, 2026
[The degradation of p27 and cancer]
Shuhei Kotoshiba1, Keiichi Nakayama
1Department of Molecular and Cellular Biology, Medical Institute of Bioregulation, Kyushu University.
Abstract:
The cell cycle of eukaryotic cells is regulated by a series of protein complexes composed of cyclins and cyclin-dependent kinases (CDKs), the activity of which is suppressed by a group of CDK inhibitors (CKIs). Among the CKIs, p27 plays a pivotal role in the control of cell proliferation. Degradation of p27 is a critical event for reentry of cells into the cell cycle from G0 phase and occurs through ubiquitination by two ubiquitin ligase complexes (KPC and SCFSkP2) and subsequent degradation by the 26S-proteasome. A tumor suppressing function of p27 has been demonstrated in mouse models and studies of human tumors. This review will focus on the regulation of p27 proteolysis and its consequences for tumorigenesis.
Insights
The cell cycle regulator p27 controls cell proliferation. Its degradation, crucial for cell cycle reentry, is linked to tumor development and progression.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Context:
- Eukaryotic cell cycle progression is governed by cyclin-dependent kinases (CDKs) and their inhibitors (CKIs).
- The CKI p27 is a key regulator of cell proliferation and possesses tumor-suppressive functions.
- p27 degradation is essential for cell cycle reentry from quiescence (G0 phase).
Purpose:
- To review the regulatory mechanisms governing p27 proteolysis.
- To elucidate the link between p27 degradation and tumorigenesis.
- To highlight the significance of p27 in cell cycle control and cancer development.
Summary:
- p27 proteolysis occurs via ubiquitination by KPC and SCFSkP2 ligases, followed by 26S-proteasome degradation.
- Dysregulation of p27 degradation pathways can contribute to uncontrolled cell proliferation and cancer.
- Studies in mouse models and human tumors confirm the tumor-suppressing role of p27.
Impact:
- Understanding p27 proteolysis regulation offers insights into cell cycle control.
- Identifying aberrant p27 degradation as a driver of tumorigenesis.
- Potential therapeutic strategies targeting p27 degradation in cancer treatment.
Related Concept Videos
Abnormal Proliferation
Inhibition of Cdk Activity
Negative Regulator Molecules
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

